Details

Autor(en) / Beteiligte

• Oliva, Alessandra
• Cancelli, Francesca
• Brogi, Andrea
• Curtolo, Ambrogio
• Savelloni, Giulia
• Siccardi, Guido
• Marcelli, Giulia
• Mazzuti, Laura
• Ricci, Paolo
• Turriziani, Ombretta
• Antonelli, Guido
• Venditti, Mario
• Mastroianni, Claudio M

Titel

Convalescent plasma for haematological patients with SARS-CoV-2 pneumonia and severe depletion of B-cell lymphocytes following anti-CD20 therapy: a single-centre experience and review of the literature

Ist Teil von

• The New microbiologica, 2022-01, Vol.45 (1), p.62-72

Ort / Verlag

Italy: Edizioni Medico Scientifiche

Erscheinungsjahr

2022

Link zum Volltext

Quelle

Elektronische Zeitschriftenbibliothek

Beschreibungen/Notizen

• Convalescent plasma (CP) therapy might be effective in patients with haematological malignanciesand B-cell depletion. We report a single-centre experience of COVID-19 patients with non-Hodgkinlymphoma and absence of B-cells as a consequence of anti-CD20 therapy successfully treated withCP from October 2020 to May 2021. CP was given in the presence of pneumonia with respiratoryfailure despite standard treatment and consisted of three infusions on an alternate-day basis. A reviewof the current literature on this topic was also performed. Six patients were identified (medianage 59.5 years (range 50-73)). The last anti-CD20 drug administration occurred 60 days before infection(range 0-360). CP was administered after a median of 51 days (range 9-120) from SARS-CoV-2diagnosis, with an early improvement in all but one subject. We suggest a possible clinical benefitof convalescent CP treatment in COVID-19 patients with haematological malignancies and B-celldepletion having persistent/recurrent pneumonia.